Cell Transdifferentiation: A Challenging Strategy with Great Potential.


Journal

Cellular reprogramming
ISSN: 2152-4998
Titre abrégé: Cell Reprogram
Pays: United States
ID NLM: 101528176

Informations de publication

Date de publication:
08 2023
Historique:
medline: 18 8 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: ppublish

Résumé

With the discovery and development of somatic cell nuclear transfer, cell fusion, and induced pluripotent stem cells, cell transdifferentiation research has presented unique advantages and stimulated a heated discussion worldwide. Cell transdifferentiation is a phenomenon by which a cell changes its lineage and acquires the phenotype of other cell types when exposed to certain conditions. Indeed, many adult stem cells and differentiated cells were reported to change their phenotype and transform into other lineages. This article reviews the differentiation of stem cells and classification of transdifferentiation, as well as the advantages, challenges, and prospects of cell transdifferentiation. This review discusses new research directions and the main challenges in the use of transdifferentiation in human cells and molecular replacement therapy. Overall, such knowledge is expected to provide a deep understanding of cell fate and regulation, which can change through differentiation, dedifferentiation, and transdifferentiation, with multiple applications.

Identifiants

pubmed: 37471050
doi: 10.1089/cell.2023.0015
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-161

Auteurs

Fuping Wang (F)

Molecular Biology Laboratory, Zhengzhou Normal University, Zhengzhou China.
School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.

Runting Li (R)

Molecular Biology Laboratory, Zhengzhou Normal University, Zhengzhou China.

Limeng Zhang (L)

Molecular Biology Laboratory, Zhengzhou Normal University, Zhengzhou China.

Xiaoning Nie (X)

Molecular Biology Laboratory, Zhengzhou Normal University, Zhengzhou China.

Linqing Wang (L)

Molecular Biology Laboratory, Zhengzhou Normal University, Zhengzhou China.

Longxin Chen (L)

Molecular Biology Laboratory, Zhengzhou Normal University, Zhengzhou China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH